Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Sep 4;64(34):944-7.
doi: 10.15585/mmwr.mm6434a4.

Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

Miwako Kobayashi, Nancy M Bennett, Ryan Gierke, Olivia Almendares, Matthew R Moore, Cynthia G Whitney, Tamara Pilishvili
Free article

Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

Miwako Kobayashi et al. MMWR Morb Mortal Wkly Rep. .
Free article

Erratum in

  • Erratum: Vol. 64, No. 34.
    [No authors listed] [No authors listed] MMWR Morb Mortal Wkly Rep. 2015 Oct 30;64(42):1204. doi: 10.15585/mmwr.mm6442a7. MMWR Morb Mortal Wkly Rep. 2015. PMID: 26512547 No abstract available.

Abstract

Two pneumococcal vaccines are currently licensed for use in the United States: the 13-valent pneumococcal conjugate vaccine (PCV13 [Prevnar 13, Wyeth Pharmaceuticals, Inc., a subsidiary of Pfizer Inc.]) and the 23-valent pneumococcal polysaccharide vaccine (PPSV23 [Pneumovax 23, Merck and Co., Inc.]). The Advisory Committee on Immunization Practices (ACIP) currently recommends that a dose of PCV13 be followed by a dose of PPSV23 in all adults aged ≥65 years who have not previously received pneumococcal vaccine and in persons aged ≥2 years who are at high risk for pneumococcal disease because of underlying medical conditions (Table) (1-4). The recommended intervals between PCV13 and PPSV23 given in series differ by age and risk group and the order in which the two vaccines are given (1-4).

PubMed Disclaimer

Substances